| Coronavirus politics: The comparative politics and policy of COVID-19 SL Greer, E King, E Massard da Fonseca, A Peralta-Santos University of Michigan Press, 2021 | 300 | 2021 |
| Measuring the Burden of Infodemics: Summary of the Methods and Results of the Fifth WHO Infodemic Management Conference E Wilhelm, I Ballalai, ME Belanger, P Benjamin, C Bertrand-Ferrandis, ... JMIR Infodemiology 3 (1), e44207, 2023 | 54 | 2023 |
| Repurposing of medicines in the EU: launch of a pilot framework C Asker-Hagelberg, T Boran, C Bouygues, SM Eskola, L Helmle, ... Frontiers in Medicine 8, 2879, 2022 | 25 | 2022 |
| UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP M Hogervorst, R Vreman, I Heikkinen, I Bagchi, I Gutierrez-Ibarluzea, ... International Journal of Technology Assessment in Health Care, 1-25, 2023 | 24 | 2023 |
| The accountability of the private sector towards citizens in times of crisis: vaccines, medicines and equipment E Petelos, D Lingri, J Ghattas, SMAA Evers, DZ Paget, C de Waure European Journal of Public Health 31 (Supplement_4), iv54-iv58, 2021 | 4 | 2021 |
| The COVID-19 Pandemic and Refugees in Greece: A New Challenge for Healthcare Service Provision, Public Health Programmes and Policymaking E Petelos, D Lingri, D Patestos, C Lionis Challenging Mobilities in and to the EU during Times of Crises, 299, 2022 | 3 | 2022 |
| Patient and citizen engagement, and deliberative processes in COVID-19 vaccine assessment E Petelos, W Oortwijn, D Lingri, V Strammiello European Journal of Public Health 31 (Supplement_3), ckab164. 427, 2021 | 2 | 2021 |
| COVID-19 passes and public health law: Considerations for surveillance and social justice D Lingri, E Petelos, D Zeegers, S Valaris, C Favaretti European Journal of Public Health 31 (Supplement_3), ckab164. 826, 2021 | 1 | 2021 |
| Caught between Scylla and Charybdis E Petelos, D Lingri, C Lionis Coronavirus Politics: The Comparative Politics and Policy of COVID-19, 2021 | 1 | 2021 |
| Regulatory and legislative frameworks and their role in R&D, HTA and UHC D Lingri, E Petelos European Journal of Public Health 30 (Supplement_5), ckaa165. 160, 2020 | 1 | 2020 |
| PL003. Workplace Safety and Workforce Preparedness in a Changing Europe: Moderators: Mark Govers (Maastricht University), Markos Tselekounis (University of Piraeus) L Sharwood, D Lingri, C Lionis The European Journal of Public Health 35 (Suppl 5), ckaf165. 071, 2025 | | 2025 |
| Is the EU on track for digital public health? A checklist for assessing the national preparedness L Maaß, B Li Han Wong, MM Kuhrn, S Buttigieg, R Hrzic, M Shokralla, ... European Journal of Public Health 35 (Supplement_4), ckaf161. 030, 2025 | | 2025 |
| Protecting the rights of migrant and refugee women and girls-a public health law perspective D Lingri, E Petelos European Journal of Public Health 35 (Supplement_4), ckaf161. 622, 2025 | | 2025 |
| Overview of the EU regulatory field, its interconnectedness and challenges for national adaptation D Lingri, S Forberger European Journal of Public Health 35 (Supplement_4), ckaf161. 029, 2025 | | 2025 |
| Addressing the Infodemic from a Health Information Equity Lens TK Mackey, E Petelos, T Purnat, I Nagyova, D Lingri Population Medicine 5 (Supplement), 2023 | | 2023 |
| 4. D. Pitch presentations: Genomics, disabilities, inequalities R Mexia, D Muller, S Subramanian, D Lingri European Journal of Public Health 33, 2, 2023 | | 2023 |
| Healthcare service provision and injuries in the time of COVID-19 pandemic: A legal and regulatory perspective D Lingri, E Petelos European Journal of Public Health 31 (Supplement_3), ckab164. 667, 2021 | | 2021 |
| 11. G. Round table: EU Digital COVID Certificate: Hope for restoring freedom or simply opening Pandora's box? Organised by: EUPHA-IDC, EUPHA-ETH, EUPHA-LAW, EUPHA-HTA, ... European Journal of Public Health 31 (Supplement_3), ckab164. 825, 2021 | | 2021 |
| The response to COVID-19 and legal determinants D Lingri European Journal of Public Health 31 (Supplement_3), ckab164. 006, 2021 | | 2021 |
| Legislative Framework for Reimbursement Conditions for Gene Therapies D Ligri, C Kani, K Souliotis | | 2016 |
